BHARAT Financials

<div class='circular--portrait' style='background:#FF6600;color: #FFFAFA;font-size:4em;padding-top: 25px;;'>BI</div>
Understanding current and past BHARAT IMMUNOLOGICALS Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. We suggest to use BHARAT IMMUNOLOGICALS BIOLOG fundamental analysis to find out if markets are at this time mispricing the company. Strictly speaking you can use it to find out if BHARAT IMMUNOLOGICALS is indeed mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. We found twenty-three available financial indicators for BHARAT IMMUNOLOGICALS, which can be compared to its peers in the sector. To make sure the equity is not overpriced, please confirm all BHARAT IMMUNOLOGICALS BIOLOG financials, including its Operating Margin, Revenue, Debt to Equity, as well as the relationship between Price to Earning and Net Income .

Search Fundamentals

 
Refresh
With this module, you can analyze BHARAT financials for your investing period. You should be able to track the changes in BHARAT IMMUNOLOGICALS individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
49%49%

Chance of Financial Distress

BHARAT IMMUNOLOGICALS BIOLOG has less than 49 (%) percent chance of experiencing financial distress in the next two years of operations. The calculation of ods of distress for BHARAT IMMUNOLOGICALS stock is tightly coupled with the Probability of Bankruptcy. It complements the equity performance score by supplying investors with insight into company financials without requiring them to know too much about all of the complex accounting and financial indicators surrounding the entity. More Info

BHARAT IMMUNOLOGICALS Company Summary

Bharat Immunologicals Biologicals Corporation Limited, a biotechnology company, manufactures and markets a range of pharmaceuticals products in India. The company was founded in 1989 and is based in Bulandshahr, India. BHARAT IMMUNOLOGICALS operates under Biotechnology classification in India and is traded on Bombay Stock Exchange.
InstrumentIndia Stock View All
ExchangeBombay Stock Exchange
Business AddressOPV Plant
SectorHealthcare
IndustryBiotechnology
BenchmarkDOW
Websitebibcol.in
Phone91 57 3223 8757
CurrencyINR

BHARAT IMMUNOLOGICALS Key Financial Ratios

BHARAT Financial Ratios Relationships

BHARAT IMMUNOLOGICALS BIOLOG is number one stock in price to earning category among related companies. It is number one stock in operating margin category among related companies .

BHARAT IMMUNOLOGICALS Market Fundamentals

Follow Benchmarks with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Check out Trending Equities. Please also try Money Flow Index module to determine momentum by analyzing money flow index and other technical indicators.
Company logos by clearbit
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page